8:32 am OncoMed Pharma initiates second Phase 1b clinical trial for OMP-54F28 (Fzd8-Fc) with Sorafenib (Nexavar(R)) in Hepatocellular Cancer
View todays social media effects on OMED
View the latest stocks trending across Twitter. Click to view dashboard